After valsartan recall, study offers 'modest reassurance' on short-term cancer risk

After valsartan recall, study offers 'modest reassurance' on short-term cancer risk  CNN Recalled blood pressure drugs not linked to increased short term cancer risk  EurekAlert (press release) Valsartan: Heart Drug Recalled by FDA Does Not Raise Cancer Risk Short-term  NewsweekFull coverage

(CLICK HERE TO READ AND SEE MORE)